BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ji L, Shen W, Zhang F, Qian J, Jiang J, Weng L, Tan J, Li L, Chen Y, Cheng H, Sun D. Worenine reverses the Warburg effect and inhibits colon cancer cell growth by negatively regulating HIF-1α. Cell Mol Biol Lett 2021;26:19. [PMID: 34006215 DOI: 10.1186/s11658-021-00263-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Mostafavi S, Zalpoor H, Hassan ZM. The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors. Cell Mol Biol Lett 2022;27. [DOI: 10.1186/s11658-022-00356-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Cui Y, Li C, Sang F, Cao W, Qin Z, Zhang P. Natural products targeting glycolytic signaling pathways-an updated review on anti-cancer therapy. Front Pharmacol 2022;13:1035882. [DOI: 10.3389/fphar.2022.1035882] [Reference Citation Analysis]
3 Lai GH, Wang F, Nie DR, Lei SJ, Wu ZJ, Cao JX, Tang LL. Correlation of Glucose Metabolism with Cancer and Intervention with Traditional Chinese Medicine. Evid Based Complement Alternat Med 2022;2022:2192654. [PMID: 36276846 DOI: 10.1155/2022/2192654] [Reference Citation Analysis]
4 Pralea I, Petrache A, Tigu AB, Gulei D, Moldovan R, Ilieș M, Nicoară R, Hegheș S, Uifălean A, Iuga C. Phytochemicals as Regulators of Tumor Glycolysis and Hypoxia Signaling Pathways: Evidence from In Vitro Studies. Pharmaceuticals 2022;15:808. [DOI: 10.3390/ph15070808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wang Y, Qian M, Du Y, Zhou J, Huo T, Guo W, Akhtar M, Huang R. Tumor-Selective Biodegradation-Regulated Photothermal H2 S Donor for Redox Dyshomeostasis- and Glycolysis Disorder-Enhanced Theranostics. Small 2022;:e2106168. [PMID: 35023625 DOI: 10.1002/smll.202106168] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 He L, Zhong Z, Chen M, Liang Q, Wang Y, Tan W. Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers. Front Pharmacol 2022;12:775084. [DOI: 10.3389/fphar.2021.775084] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Zhao N, Zhang J, Zhao Q, Chen C, Wang H. Mechanisms of Long Non-Coding RNAs in Biological Characteristics and Aerobic Glycolysis of Glioma. Int J Mol Sci 2021;22:11197. [PMID: 34681857 DOI: 10.3390/ijms222011197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Zhou C, Zhou H, Zhang F, Hao L, Guo J. Active Ingredients and Potential Mechanisms of the Gan Jiang-Huang Qin-Huang Lian-Ren Shen Decoction against Ulcerative Colitis: A Network Pharmacology and Molecular Docking-Based Study. Evid Based Complement Alternat Med 2021;2021:1925718. [PMID: 34539797 DOI: 10.1155/2021/1925718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wei Y, Ren S, Wang R, Jing M, Liu H, Wang M, Song H, Zhao Y. Based on Network Pharmacology to Explore the Potential Bioactive Compounds and Mechanisms of Zuojin Pill for the Treatment of Ulcerative Colitis. Evid Based Complement Alternat Med 2021;2021:7567025. [PMID: 34484403 DOI: 10.1155/2021/7567025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]